Integral Diagnostics launches retail entitlement offer

Company News

by Anna Napoli

Medical imaging services company, Integral Diagnostics (ASX:IDX) will kick off its retail entitlement offer today.

The entitlement offer is intended to raise gross proceeds of approximately A$72 million.

Funds raised will go towards the $104 million acquisition of Imaging Queensland which Integral announced last week.

Integral expexts the acquisition to complete in November 2019.

Shares in Integral Diagnostics (ASX:IDX) closed 1.3 per cent higher at $3.10.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.